Marketing Pharmaceuticals 2015: Drug/Device Marketing in an Evolving Environment
Feb 18 2015 8:00AM - Feb 19 2015 5:00PM | Washington Marriott Wardman Park
2660 Woodley Road, NW,
Washington, DC 20008
The Marketing Pharmaceuticals 2015 meeting offers interested companies the opportunity to exhibit with a tabletop display.
Tabletop Fee: $1,500
- One six-foot skirted table
- One chair
- Standard electricity
Each tabletop rental requires at least one registered attendee to staff the table. All tabletop staff must be registered conference attendees.
Tabletop Exhibit Dates:
February 18-19, 2014
- Gilead Sciences
- Opus Regulatory, Inc.
- PharmaCloud, LLC
- Veeva Systems Inc
- Zinc Ahead, Inc.
- Member Government
- Member Academia
- Member Standard
- Member Standard (As of 01/23/2015)
- NonMember Government
- NonMember Academia
- NonMember Standard
Registration Fees for Additional Offerings
- OPDP/APLB and Compliance 101 - Tutorial #1 Rate
Register three individuals from the same company and receive complimentary registration for a fourth! All four individuals must register and prepay at the same time – no exceptions. DIA will apply the value of the lowest applicable fee to this complimentary registration; it does NOT include fees for optional events or DIA membership. You may substitute group participants of the same membership status at any time; however, administrative fees may be incurred.
Group registration is not available online and does not apply to the already-discounted fees for government or charitable nonprofit/academia. To take advantage of this offer, please print a registration form for EACH of the four registrants from your company. Include the names of all four group registrants on each of the forms and return them together to DIA.
Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.